Literature DB >> 29451668

Comparison between early and delayed facial nerve decompression in traumatic facial nerve paralysis - A retrospective study.

David Victor Kumar Irugu1, Anoop Singh1, Sravan Ch2, Achyuth Panuganti3, Anand Acharya4, Hitesh Varma1, Ramya Thota1, Maurizio Falcioni5, Sridhar Reddy3.   

Abstract

Purpose To study the intraoperative findings in case of early and delayed decompression of facial nerve paralysis and compare their results. Methods Retrospective data analysis of 23 cases of longitudinal temporal bone fracture with House-Brackmann grade V and VI facial nerve paralysis. All cases were thoroughly evaluated and underwent facial nerve decompression through the transmastoid approach. All cases were under regular follow-up till the date of manuscript submission. Results Clinical improvement of the facial nerve function was observed for early vs. delayed facial nerve decompression. In the early decompression group, facial nerve function improved to grade II in eight cases (80%) and grade III in two cases (20%), whereas in the delayed decompression group it improved to grade II in one case (7.70%), grade III in four cases (30.76%), grade IV in seven cases (53.84%), and grade V in one case (7.70%). Conclusions Early decompression of facial nerve provides better results than delayed decompression because it enables early expansion of the nerve.

Entities:  

Mesh:

Year:  2018        PMID: 29451668     DOI: 10.1590/2317-1782/20182017063

Source DB:  PubMed          Journal:  Codas        ISSN: 2317-1782


  2 in total

Review 1.  Surgical anatomy of the facial nerve: from middle cranial fossa approach to endoscopic approach. A pictorial review.

Authors:  Davide Soloperto; Flavia Di Maro; Beatrice Le Pera; Daniele Marchioni
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-02-12       Impact factor: 2.503

2.  Surgical Outcomes of Transmastoid Facial Nerve Decompression for Patients With Traumatic Facial Nerve Paralysis.

Authors:  Harun Gür; Kemal Görür; Onur İsmi; Yusuf Vayısoğlu; Kemal Koray Bal; Cengiz Özcan
Journal:  J Int Adv Otol       Date:  2021-07       Impact factor: 1.017

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.